CLINICAL EXPERIENCE WITH ANTAGONIST-INDUCED OPIATE WITHDRAWAL UNDER ANAESTHESIA

Documenti analoghi

• ANTAGONIST-PRECIPITATED HEROIN WITHDRAWAL UNDER ANAESTHETIC PRIOR TO MAINTENANCE NALTREXONE TREATMENT. DETERMINANTS OF WITHDRAWAL SEVERITY
  di: ALI, R.
  Pubblicazione: (2004)
• OPIOID ANTAGONIST DETOXIFICATION UNDER ANAESTHESIA VERSUS TRADITIONAL CLONIDINE DETOXIFICATION COMBINED WITH AN ADDICTIONAL WEEK OF PSYCHOSOCIAL SUPPORT: A RANDOMISED CLINICAL TRIAL
  di: FAVRAT, B.
  Pubblicazione: (2006)
• OPIATE DETOXIFICATION UNDER ANESTHESIA: NO APPARENT BENEFIT BUT SUPPRESSION OF THYROID HORMONES AND RISK OF PULMONARY AND RENAL FAILURE
  di: PFAB, R.
  Pubblicazione: (2000)
• CLINICAL FEATURES AND MANAGEMENT OF GAMMA-HYDROXYBUTYRATE (GHB) WITHDRAWAL: A REVIEW
  di: MCDONOUGH, M.
  Pubblicazione: (2004)
• The impact of the opioid antagonist naloxone on experimentally induced craving in nicotine-dependent individuals
  di: Krause, D.
  Pubblicazione: (2018)